Sneak Peek: 3 Stocks from Our Top Picks of 2026 Report

• BMY has reclaimed its 200-month moving average and could benefit from capital rotation to cash-generative pharma stocks if interest rates remain stable
• CCJ is up over 80% year-to-date, capitalizing on increased nuclear power demand from AI data centers and geopolitical tensions favoring western suppliers
• GCT broke through a downtrend in late 2025 and hit a fresh 52-week peak in December at $36.75, three times its IPO price

Market Summary: Schaeffer's Research Top Stock Picks for 2026

Schaeffer's Research has released its Top Stock Picks of 2026 report, highlighting three companies positioned for potential outperformance: Bristol-Myers Squibb (BMY), Cameco (CCJ), and GigaCloud Technology (GCT).

Bristol-Myers Squibb (BMY) - The pharmaceutical giant is expected to benefit from capital rotation into cash-generative equities if interest rates remain lower or stable in 2026. BMY has reclaimed its 200-month moving average and a long-term trendline connecting higher highs from 2004-2012, screening favorably on free cash flow yield and dividend sustainability.

Cameco (CCJ) - The uranium producer is capitalizing on increased demand for alternative energy sources, particularly nuclear power. Currently up over 80% year-to-date, CCJ broke out of its 2024 trading range between $35-$60. Key drivers include AI-related power demand for data centers, Trump administration support for nuclear energy, and geopolitical tensions favoring Western suppliers in the U.S.-China AI race.

GigaCloud Technology (GCT) - The e-commerce stock broke through a downtrend in late 2025 and reached a fresh 52-week peak in December, clearing $36.75—three times its IPO price of $12.25. The stock is rising with support from its 20-day moving average. Limited analyst coverage (five analysts) and 2.62 million shares short could create additional tailwinds through increased attention and potential short squeeze dynamics.

The report also mentions Baidu (BIDU), up over 40% in 2025, though full details require subscription access. These selections reflect a strategic shift from 2025's growth-focused winners to potentially different market leaders in 2026.